CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor

Annals of the New York Academy of Sciences

Volumn 902, Issue , 2000, Pages 128-133

  Nicholson, Andrew C ^a   Febbraio, Maria ^a   Han, Jihong ^a   Silverstein, Roy L ^a   Hajjar, David P ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CD36 ANTIGEN; LIGAND; LIPOPROTEIN RECEPTOR; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN KINASE C INHIBITOR; SCAVENGER RECEPTOR; TRANSCRIPTION FACTOR;

ATHEROSCLEROSIS; CONFERENCE PAPER; GENE EXPRESSION REGULATION; MACROPHAGE; MOUSE; MOUSE MUTANT; NONHUMAN;

ANIMALIA;

EID: 0034081958     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06307.x     Document Type: Conference Paper

References (22)

1. 1. ACTON, S., R. ATTILIO, K. LANDSCHULTZ, S. XU, H. HOBBS & M. KRIEGER. 1996. Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science 271: 518.
2. 2. TALLE, M., P. RAO, E. WESTBERG, N. ALLEGAR, M. MAKOWSKI, R. MITTLER & G. GOLDSTEIN. 1983. Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies. Cell. Immunol. 78: 83.
3. 3. LI, Y.S., Y.J. SHYY, J.G. WRIGHT, A.J. VALENTE, J.F. CORNHILL & P.E. KOLATTUKUDY. 1993. The expression of monocyte chemotactic protein (MCP-1) in human vascular endothelium in vitro and in vivo. Mol. Cell Biochem. 126: 61.
4. 4. GREENWALT, D., R. LIPSKY, C. OCKENHOUSE, H. IKEDA, N. TANDON & G. JAMIESON. 1992. Membrane glycoprotein CD36: A review if its roles in adherence, signal transduction, and transfusion medicine. Blood 80: 1105.
5. 5. ABUMRAD, N., M.R. EL-MAGHRABI, E. AMRI, E. LOPEZ & P. GRIMALDI. 1993. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. J. Biol. Chem 268: 17665.
6. 6. KRIEGER, M., S. ACTON, J. ASHKENAS, A. PEARSON, M. PENMAN & D. RESNICK. 1993. Molecular flypaper, host defense, and atherosclerosis. J. Biol. Chem. 268: 4569.
7. 7. ENDEMANN, G., L. STANTON, K. MADDEN, K. BRYANT, R.T. WHITE & A. PROTTER. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268: 11811.
8. 8. NICHOLSON, A., S.F.A. PEARCE & R. SILVERSTEIN. 1995. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscl. Thromb. 15: 269.
9. 9. RIGOTTI, A., S. ACTON & M. KRIEGER. 1995. The class B scavenger receptors SR-B1 and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 270: 16221.
10. 10. REN, Y., R. SILVERSTEIN, J. ALLEN & J. SAVILL. 1995. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med. 181: 1857.
11. 11. ASCH, A., J. BARNWELL, R. SILVERSTEIN & R. NACHMAN. 1987. Isolation of the thrombospondin membrane receptor. J. Clin. Invest. 79: 1054.
12. 12. TANDON, N., U. KRALISZ & G. JAMIESON. 1989. Identification of GPIV (CD36) as a primary receptor for platelet-collagen adhesion. J. Biol. Chem. 264: 7576.
13. 13. BARNWELL, J., C. OCKENHOUSE & D. KNOWLES. 1985. Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum infected erythrocytes to monocytes, endothelial, and C32 melanoma cells. J. Immunol. 135: 3494.
14. 14. PARTHASARATHY, S., L. FONG, D. OTERO & D. STEINBERG. 1987. Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. Proc. Natl. Acad. Sci. USA 84: 537.
15. 15. CALVO, D., D. GOMEZ-CORONADO, Y. SUAREZ, M. LASUNCION & M.A. VEGA. 1998. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J. Lipid Res. 39: 777.
16. 16. CONNELLY, M.A., S. KLEIN, S. AZHAR, N. ABUMRAD & D L. WILLIAMS. 1999. Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J. Biol. Chem. 274:41.
17. 17. HUH, H.-Y., S.F.A. PEARCE, L. YESNER & R.L. SILVERSTEIN. 1996. Regulated expression of CD36 during monocyte-to-macrophage differentiation: Potential role of CD36 in foam cell formation. Blood 87: 2020.
18. 18. YESNER, L., H. HUH, S.F.A. PEARCE & R. SILVERSTEIN. 1996. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscl. Thromb. 16: 1019.
19. 19. HAN, J., D.P. HAJJAR, M. FEBBRAIO & A.C. NICHOLSON. 1997. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J. Biol. Chem. 272: 21654.
20. 20. HAN, J., D.P. HAJJAR, J.M. TAURAS & A.C. NICHOLSON. 1999. Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36. J. Lipid Res. 40: 830-838
21. 21. TONTONOZ, P., L. NAGY, J. ALVAREZ, V. THOMAZY & R. EVANS. 1998. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241.
22. 22. NAGY, L., P. TONTONOZ, J. ALVAREZ, H. CHEN & R. EVANS. 1998. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93: 229.